Figure 1. Flow diagram of 403 patients included in the Nordic Myeloma Study Group bortezomib consolidation study.
Figure 1

Flow diagram of 403 patients included in the Nordic Myeloma Study Group bortezomib consolidation study.

This Feature Is Available To Subscribers Only

or Create an Account

Close Modal
Close Modal